7 α -Substituted androstenediones as effective in vttro and in vivo inhibitors of aromatase

[1]  R. Brueggemeier,et al.  Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture. , 1987, Cancer research.

[2]  R. Brueggemeier,et al.  Potent enzyme-activated inhibition of aromatase by a 7 alpha-substituted C19 steroid. , 1987, The Journal of biological chemistry.

[3]  R. Brueggemeier,et al.  7α-SUBSTITUTED DERIVATIVES OF ANDROSTENEDIONE AS INHIBITORS OF ESTROGEN BIOSYNTHESIS , 1985 .

[4]  P. Bednarski,et al.  Thiol-containing androgens as suicide substrates of aromatase. , 1985, Journal of medicinal chemistry.

[5]  R. Brueggemeier,et al.  7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis. , 1985, Journal of medicinal chemistry.

[6]  R. Brueggemeier,et al.  Covalent modification of aromatase by a radiolabeled irreversible inhibitor. , 1985, Journal of steroid biochemistry.

[7]  M. Dowsett,et al.  4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER , 1984, The Lancet.

[8]  B. Metcalf,et al.  Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase. , 1984, Endocrinology.

[9]  R. Rando.  Mechanism-based enzyme inactivators. , 1984, Pharmacological reviews.

[10]  R. Brueggemeier,et al.  A photoaffinity inhibitor of aromatase , 1982, Steroids.

[11]  D. Covey,et al.  Comparative studies of aromatase inhibitors in cultured human breast cancer cells. , 1982, Cancer research.

[12]  C. Tsai-Morris,et al.  Effect of an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat and its mechanism of action in vivo. , 1982, Biochemical pharmacology.

[13]  P. Marcotte,et al.  Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues. , 1982, Biochemistry.

[14]  P. Marcotte,et al.  Synthesis and evaluation of 10β-substituted 4-estrene-3,17-diones as inhibitors of human placental microsomal aromatase , 1982, Steroids.

[15]  C. Tsai-Morris,et al.  Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo , 1981, Steroids.

[16]  A. Sjoerdsma.  Suicide enzyme inhibitors as potential drugs , 1981, Clinical pharmacology and therapeutics.

[17]  B. Metcalf,et al.  Substrate-induced inactivation of aromatase by allenic and acetylenic steroids , 1981 .

[18]  D. Covey,et al.  Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity. , 1981, Endocrinology.

[19]  D. Covey,et al.  10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis. , 1981, The Journal of biological chemistry.

[20]  J. MacIndoe.  Estradiol formation from testosterone by continuously cultured human breast cancer cells. , 1979, The Journal of clinical endocrinology and metabolism.

[21]  A. Brodie,et al.  Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione. , 1979, Journal of steroid biochemistry.

[22]  R. Santen,et al.  Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. , 1978, The Journal of clinical endocrinology and metabolism.

[23]  W. McGuire,et al.  Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. , 1978, Endocrinology.

[24]  R. Brueggemeier,et al.  Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis. , 1978, Journal of medicinal chemistry.

[25]  W. McGuire,et al.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. , 1978, The Journal of biological chemistry.

[26]  A. Brodie,et al.  The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. , 1977, Endocrinology.

[27]  W. McGuire,et al.  MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors , 1975, Steroids.

[28]  B. Katzenellenbogen,et al.  Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. , 1982, Cancer research.

[29]  C. Walsh.  Suicide substrates: mechanism-based enzyme inactivators , 1982 .

[30]  D. Covey,et al.  Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione. , 1982, Molecular pharmacology.